Literature DB >> 28810739

A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies.

Jun Ohata1, Zachary T Ball1.   

Abstract

Preparation of antibody-drug conjugates (ADCs), an emerging novel class of highly targeted biological hybrid agents, necessitates precise control of conjugation reactivity. Antibodies have complex multistranded architectures, and specific modification of natural antibodies has proven quite challenging. Here, we demonstrate that cooperative activity of a multimetallic metallopeptide enables efficient site-specific antibody functionalization, based on molecular recognition of the constant Fc region. This interplay of multiple metal centers enables introduction of an orthogonal alkyne handle into monoclonal or polyclonal antibodies from different species in an Fc-specific fashion. Elaboration of this simple functionalization allows preparation of conjugates with fluorophore, affinity handle, and pharmacological agents. This method opens a new opportunity for quick and easy production of well-defined antibody conjugates from a variety of antibody sequence and species of origin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28810739     DOI: 10.1021/jacs.7b06428

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

1.  Synthesis and structure-activity relationship studies of IgG-binding peptides focused on the C-terminal histidine residue.

Authors:  Kyohei Muguruma; Mayu Ito; Akane Fukuda; Satoshi Kishimoto; Akihiro Taguchi; Kentaro Takayama; Atsuhiko Taniguchi; Yuji Ito; Yoshio Hayashi
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

2.  Site-Specific Bioconjugation and Multi-Bioorthogonal Labeling via Rapid Formation of a Boron-Nitrogen Heterocycle.

Authors:  Tak Ian Chio; Han Gu; Kamalika Mukherjee; L Nathan Tumey; Susan L Bane
Journal:  Bioconjug Chem       Date:  2019-05-03       Impact factor: 4.774

3.  Expanding the Scope of Antibody Rebridging with New Pyridazinedione-TCO Constructs.

Authors:  Angela N Marquard; Jonathan C T Carlson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2020-04-28       Impact factor: 4.774

4.  Aminoquinoline-Rhodium(II) Conjugates as Src-Family SH3 Ligands.

Authors:  Samuel C Martin; Zachary T Ball
Journal:  ACS Med Chem Lett       Date:  2019-09-09       Impact factor: 4.345

5.  Precision Modification of Native Antibodies.

Authors:  Kuan-Lin Wu; Chenfei Yu; Catherine Lee; Chao Zuo; Zachary T Ball; Han Xiao
Journal:  Bioconjug Chem       Date:  2021-08-24       Impact factor: 4.774

6.  A DNA-conjugated small molecule catalyst enzyme mimic for site-selective ester hydrolysis.

Authors:  Moira L Flanagan; A Emilia Arguello; Drew E Colman; Jiyeon Kim; Jesse N Krejci; Shimu Liu; Yueyu Yao; Yu Zhang; David J Gorin
Journal:  Chem Sci       Date:  2018-01-15       Impact factor: 9.825

7.  Labeling and Natural Post-Translational Modification of Peptides and Proteins via Chemoselective Pd-Catalyzed Prenylation of Cysteine.

Authors:  Thomas Schlatzer; Julia Kriegesmann; Hilmar Schröder; Melanie Trobe; Christian Lembacher-Fadum; Simone Santner; Alexander V Kravchuk; Christian F W Becker; Rolf Breinbauer
Journal:  J Am Chem Soc       Date:  2019-09-09       Impact factor: 15.419

8.  An optimal "Click" formulation strategy for antibody-drug conjugate synthesis.

Authors:  Erol C Vatansever; Jeffrey Kang; Alfred Tuley; E Sally Ward; Wenshe Ray Liu
Journal:  Bioorg Med Chem       Date:  2020-10-06       Impact factor: 3.641

9.  Cysteine-specific protein multi-functionalization and disulfide bridging using 3-bromo-5-methylene pyrrolones.

Authors:  Yingqian Zhang; Chuanlong Zang; Guoce An; Mengdi Shang; Zenghui Cui; Gong Chen; Zhen Xi; Chuanzheng Zhou
Journal:  Nat Commun       Date:  2020-02-21       Impact factor: 14.919

Review 10.  Affinity-Based Methods for Site-Specific Conjugation of Antibodies.

Authors:  Emma von Witting; Sophia Hober; Sara Kanje
Journal:  Bioconjug Chem       Date:  2021-08-09       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.